炎症性2型经典树突状细胞参与小鼠和人类胆管炎
该研究在小鼠胆管炎模型中通过流式细胞术检测树突状细胞数量与亚型,并经免疫荧光显微镜证实,同时比较PSC患者与减重手术对照的肝样本;采用遗传工具清除特定树突状细胞亚群,并用单细胞转录组学分析。结果显示胆管炎以肝内2型经典树突状细胞选择性扩增及炎症成熟为特征,该亚群具促炎作用,其炎症介质或为PSC潜在治疗靶点。
要点
- 胆管炎小鼠模型肝内2型经典树突状细胞选择性扩增,浆细胞样和1型经典树突状细胞未扩增。
- 人PSC病灶中2型经典树突状细胞扩增经组织学证实。
- 清除2型经典树突状细胞显示其促炎作用,单细胞转录组学确认其炎症成熟并鉴定相关炎症介质。
核心结论
- 胆管炎以胆管损伤后肝内2型经典树突状细胞扩增和炎症成熟为特征。
- 2型经典树突状细胞及其炎症介质可能是治疗PSC的潜在治疗靶点。
研究设计与样本
- 研究在小鼠胆管炎模型中用流式细胞术基于谱系印记标记检测树突状细胞数量和亚型。
- 用小鼠肝脏免疫荧光显微镜证实发现,并将PSC患者肝样本与减重手术患者对照样本比较。
- 利用遗传工具在小鼠胆管炎中清除选定树突状细胞亚群。
- 通过单细胞转录组学确定树突状细胞对胆管损伤的反应。
主要发现
- 胆管炎小鼠模型以肝内2型经典树突状细胞选择性扩增为特征,而浆细胞样和1型经典树突状细胞未扩增。
- 人PSC病灶中2型经典树突状细胞扩增经组织学证实。
- 清除研究揭示2型经典树突状细胞具促炎作用。
- 单细胞转录组学证实肝内2型经典树突状细胞的炎症成熟,并鉴定出树突状细胞来源的炎症介质。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Primary sclerosing cholangitis (PSC) is a progressive cholangiopathy characterised by fibrotic stricturing and inflammation of bile ducts, which seems to be driven by a maladaptive immune response to bile duct injury. The histological finding of dendritic cell expansion in portal fields of patients with PSC prompted us to investigate the role of dendritic cells in orchestrating the immune response to bile duct injury. METHODS: Dendritic cell numbers and subtypes were determined in different mouse models of cholangitis by flow cytometry based on lineage-imprinted markers. Findings were confirmed by immunofluorescence microscopy of murine livers, and liver samples from patients with PSC were compared to control samples from bariatric surgery patients. Using genetic tools, selected dendritic cell subsets were depleted in murine cholangitis. The dendritic cell response to bile duct injury was determined by single-cell transcriptomics. RESULTS: Cholangitis mouse models were characterised by selective intrahepatic expansion of type 2 conventional dendritic cells, whereas plasmacytoid and type 1 conventional dendritic cells were not expanded. Expansion of type 2 conventional dendritic cells in human PSC lesions was confirmed by histology. Depletion studies revealed a proinflammatory role of type 2 conventional dendritic cells. Single-cell transcriptomics confirmed inflammatory maturation of the intrahepatic type 2 conventional dendritic cells and identified dendritic cell-derived inflammatory mediators. CONCLUSIONS: Cholangitis is characterised by intrahepatic expansion and inflammatory maturation of type 2 conventional dendritic cells in response to biliary injury. Therefore, type 2 conventional dendritic cells and their inflammatory mediators might be potential therapeutic targets for the treatment of PSC. LAY SUMMARY: Primary sclerosing cholangitis (PSC) is an inflammatory liver disease of the bile ducts for which there is no effective treatment. Herein, we show that the inflammatory immune response to bile duct injury is organised by a specific subtype of immune cell called conventional type 2 dendritic cells. Our findings suggest that this cell subtype and the inflammatory molecules it produces are potential therapeutic targets for PSC.
引用
- Müller AL, Casar C, Preti M, et al. Inflammatory type 2 conventional dendritic cells contribute to murine and human cholangitis. J Hepatol. 2022. PMID: 35798133. doi:10.1016/j.jhep.2022.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。